Clinical Trial Update: A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic

View source ↗

Summary

This clinical trial update describes a long-term observational study to evaluate the safety of a gene-modified regulatory T cell therapy in participants, sponso…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa
• Rheumatoid Arthritis

Drugs mentioned

• Treg gene-modified regulatory T cell therapy

Snippet

Sponsor: Sonoma Biotherapeutics, Inc. | Conditions: Rheumatoid Arthritis (RA), Hidradenitis Suppurativa (HS) | Status: RECRUITING